Novartis AG
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| NOVN.SW | AMGN | AZN | BIIB | SNY | MRK | |
|---|---|---|---|---|---|---|
| Market cap | 228.01B | 225.75B | 245.55B | 33.90B | 95.22B | 358.85B |
| P/E (TTM) | 22.8 | 25.9 | 23.7 | 40.7 | 20.9 | 115.4 |
| Forward P/E | 14.7 | 17.0 | 14.0 | 13.9 | 7.5 | 15.6 |
| Price/book | 6.6 | 19.3 | 4.9 | 1.8 | 1.2 | 8.6 |
| Dividend yield | 3.11% | 2.43% | 2.01% | — | 6.04% | 2.34% |
| 1-year change | +13.97% | +42.10% | −7.00% | +57.88% | −17.89% | +71.72% |
| Today | +0.72% | +0.65% | −0.55% | +1.64% | −0.82% | −0.10% |
The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 15 min.
Latest news
All NOVN.SW news ›SAP’s Joule Assistants Are Now Executing Inside Production Business Workflows at Novartis, Nestlé, and PwC
The ERP incumbent just attached vendor-cited customer names to the back-office agent deployment thesis. The autonomous enterprise framing is real, but the measurement gap persists. Dana Ellison Agents at Work Enterprise AI agents,…
Novartis acquires Arctos Medical, expanding optogenetics portfolio to bring gene therapies to patients with severe vision loss
Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines…
Opinion: How Abogen went from COVID hype to a $7.8B Novartis deal
Novartis’ agreement with Abogen Biosciences stands out even in today’s increasingly busy biotech licensing market. From my vantage point working on healthcare investment banking transactions across U.S. and Asian markets, the $575 million…
Novartis AG (NYSE:NVS) Stock Has Consensus Target Price of $145.60
Posted by Sarita Garza on Oct 10th, 2026 Read Our Latest Analysis on Novartis Novartis (NYSE:NVS – Get Free Report) last released its earnings results on Tuesday, June 30th. The company reported $2.41 EPS for the quarter. The company had…
Fortune includes Novartis in 2026 Change The World List for malaria program
Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines…
Clinical Research Jobs at Novartis | Apply Now
Novartis clinical research jobs in India include an opportunity for qualified candidates to step into the role of Clinical Development Scientist at Novartis. This position is pivotal in contributing to global clinical trial activities,…
IgA Nephropathy Market to Expand Rapidly with Advancing Pipeline and Increasing Treatment Adoption by 2036 - DelveInsight | Visterra, Chinook Therapeutics, Novartis, IgA proteases Selecta Biosciences
The Key IgA Nephropathy Companies in the market include Travere Therapeutics Asahi Kasei Calliditas Therapeutics Vertex Pharmaceuticals Vera Therapeutics Visterra Chinook Therapeutics Novartis IgA proteases Selecta Biosciences Shanghai…
Novartis wins FDA nod to expand Rhapsido label to symptomatic dermographism
Novartis announced receipt of US FDA approval for Rhapsido (remibrutinib) on October 7, 2026, as the first approved treatment specifically for adults with symptomatic dermographism (SD) inadequately controlled by H1 antihistamines. The…
Novartis Rhapsido® (remibrutinib) receives FDA approval as first treatment for symptomatic dermographism (SD), expanding its use beyond chronic spontaneous urticaria (CSU)
Learn about our commitments to making a positive impact on the world by providing access to innovative medicines, protecting the environment, and upholding high ethical standards. Novartis is hiring! Find open positions, learn more about…
DKSH Singapore, Novartis Forge Ophthalmology Partnership
DKSH Singapore and Novartis have signed a strategic partnership to support access to Novartis' ophthalmology portfolio in Singapore, according to a Thursday press release. Under the partnership,... DKSH Singapore, Novartis Forge…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
-
marketscreener.com25
-
medicaldialogues.in6
-
tradingview.com4
-
firstwordpharma.com3
-
news.bloomberglaw.com3
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 119 articles, not a forecast.